Global Radiation Dose Management Market: Analysis and Forecast, 2021-2030
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
Market Report Coverage - Radiation Dose Management
Market Segmentation
Agfa-Gevaert Group, Bayer AG, Bracco, Canon Inc., Fujifilm Holdings Corporation, Guerbet Group, General Electric Company, Imalogix, Infinitt Healthcare Co., ltd., Koninklijke Philips N.V., Medic Vision Imaging Solutions Ltd., Medsquare, MyXrayDose Ltd., Novarad Coroporation, PACSHealth, LLC, Qaelum NV, Sectra AB, SST Group Inc., Siemens Healthineers, Inc., and Virtual Phantom, Inc.
Key Questions Answered in this Report:
The radiation dose management market is witnessing a significant increase in the market size due to the ongoing COVID-19 pandemic. The overall market was estimated to be $231.1 million in FY2019, and it is expected to grow at a CAGR of 10.96% during the forecast period, 2021-2030. Presently, more than 21 companies are operating in this market, including already existing and emerging medical device companies.
Healthcare experts at BIS are continuously analyzing the impact of industrial and regulatory decisions on the radiation dose management market. The market is driven by certain factors such as growing geriatric population, increasing installed bases of radiology equipment and number of scans, increasing prevalence of chronic and lifestyle associated diseases, increasing regulatory requirements for diagnostic devices, increasing concern related to radiation exposure, and growing awareness and initiatives for radiation dose management.
Within the research report, the market is segmented based on product type, patient age, end-user, and regional analysis. Each of these segments covers the market’s snapshot over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Market Report Coverage - Radiation Dose Management
Market Segmentation
- Modality-CT Scanners, X-Ray, CR and DR, Mammography System, Interventional Angiography Systems/Angio CT, Fluoroscopy systems, PET scanners and SPECT, and Hybrid Imaging.
- Mode of Deployment- Web-Based, On-Premises, and Cloud-Based
- Products- Radimetrics Enterprise Platform, DoseWatch, Teamplay Dose, Nexo [Dose], tqm/Dose and DoseMonitor, Radiation Dose Monitor, Imalogix Platform, Syncro-Dose, NovaDose, DoseWIse Portal, SafeCT, MYXrayDose, DoseM, Dose Tracking System and DoseTrack
- End-User- Hospital, Diagnostic Centers and others
- North America – U.S., Canada
- Europe – Germany, U.K., France, Italy, Spain, Netherlands, Russia and Rest-of-Europe
- Asia-Pacific – Japan, China, India, South Korea, Australia and New Zealand, and Rest-of-Asia-Pacific
- Latin America-Brazil, Mexico, and Rest-of-Latin America
- Rest-of-the-World - Middle East, and Africa
- Growing geriatric population
- Increasing installed bases of radiology equipment and number of scans
- Increasing prevalence of chronic and lifestyle associated diseases
- Increasing regulatory requirements for diagnostic devices
- Increasing concern related to radiation exposure
- Growing awareness and initiatives for radiation dose management
- Lack of skilled and trained professionals
- Lack of benchmarking of dose optimization
- High cost associated with radiation dose management system
- Technological advancements in medical imaging
- Impact of cloud-based solutions
- Regulatory focus on pediatric procedures
- Regional expansion and increasing adoption of radiation dose management software in emerging economies
Agfa-Gevaert Group, Bayer AG, Bracco, Canon Inc., Fujifilm Holdings Corporation, Guerbet Group, General Electric Company, Imalogix, Infinitt Healthcare Co., ltd., Koninklijke Philips N.V., Medic Vision Imaging Solutions Ltd., Medsquare, MyXrayDose Ltd., Novarad Coroporation, PACSHealth, LLC, Qaelum NV, Sectra AB, SST Group Inc., Siemens Healthineers, Inc., and Virtual Phantom, Inc.
Key Questions Answered in this Report:
- How has COVID-19 impacted the global radiation dose management market?
- What are the key regulations for the development, commercialization, and adoption of radiation dose management?
- How does the pricing of the radiation dose software impact the overall market growth?
- Which are the leading players that currently hold significant dominance in the global radiation dose management market?
- What are the key strategies incorporated by the players of the global radiation dose management market to sustain the competition and retain their supremacy?
- What is the patent landscape of the radiation dose management market for different modalities?
- What is the current annual demand for different radiation dose management modalities, end user, and mode of deployment across different regions? What is their growth potential over the forecast period (2021-2030)?
- What is the current market potential of radiation dose management, and what are the factors deciding the growth potential of radiation dose management for the forecast period?
- What is the current revenue contribution of different modalities, and how would it evolve in the forecast period?
- What are the various types of radiation dose management products available in the market? How many units of products have been installed in 2017, 2018, and 2019, respectively?
- Which mode of deployment contributes to the highest CAGR (%) in the global radiation dose management market?
- How does the end-user perception impact the growth of the global radiation dose management market?
- Which countries contribute to a major share of the current demand, and which countries hold significant scope for expansion for business activities by players of the global radiation dose management market?
The radiation dose management market is witnessing a significant increase in the market size due to the ongoing COVID-19 pandemic. The overall market was estimated to be $231.1 million in FY2019, and it is expected to grow at a CAGR of 10.96% during the forecast period, 2021-2030. Presently, more than 21 companies are operating in this market, including already existing and emerging medical device companies.
Healthcare experts at BIS are continuously analyzing the impact of industrial and regulatory decisions on the radiation dose management market. The market is driven by certain factors such as growing geriatric population, increasing installed bases of radiology equipment and number of scans, increasing prevalence of chronic and lifestyle associated diseases, increasing regulatory requirements for diagnostic devices, increasing concern related to radiation exposure, and growing awareness and initiatives for radiation dose management.
Within the research report, the market is segmented based on product type, patient age, end-user, and regional analysis. Each of these segments covers the market’s snapshot over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Executive Summary
1 MARKET OVERVIEW
1.1 Introduction
1.1.1 Natural Radiation Sources
1.1.2 Biological Effects of Radiation
1.1.3 Usage of Radiation in Medical Devices
1.1.4 Radiation Dose
1.1.5 Effective Radiation Dose
1.1.6 Factors Contributing to Unnecessary Radiation Exposure
2 PRODUCT DEFINITION
3 SCOPE OF RESEARCH STUDY
3.1 Scope of the Study
3.2 Exclusion Criteria of the Report
3.3 Key Questions Answered in the Report
3.4 Forecast Period Selection Criteria
4 RESEARCH SCOPE AND METHODOLOGY
4.1 Research Methodology
4.2 Primary Data Sources
4.3 Secondary Data Sources
4.4 Data and Prediction Modeling
4.5 Selection Criteria for Company Profiles
4.6 Brief Overview of Market Estimation Process
4.7 Data Validation
4.8 Assumptions and Limitations
5 COVID-19 IMPACT ANALYSIS
5.1 Impact on Radiation Diagnostic Industry
5.1.1 Industry Analysis
5.1.2 Long-, Mid-, and Short-Term Impact
5.1.3 Impact on Radiation Diagnostic Equipment (CT Scanners, X-Ray, Mammography System, PET Scanners and SPECT, and Others)
5.2 Trend Analysis for Radiation Dose Management Market
5.2.1 Pre-COVID-19
5.2.2 Post-COVID-19
5.3 Regional Impact of COVID-19 Industry
5.3.1 North America
5.3.2 Europe
5.3.3 Asia-Pacific
5.3.4 Rest-of-the-World
5.4 Change in Competitive Landscape and Product Demand
5.5 Emerging Opportunities due to COVID-19 in Radiation Dose Management
5.6 Future Prospective: Post COVID-19 Scenarios and Recommendations
6 GLOBAL RADIATION DOSE MANAGEMENT MARKET SCENARIO
6.1 Historical Trends
6.2 Trends for Radiation Dose Management
6.3 Global Radiation Dose Management Scenario
6.4 Assumptions and Limitations
6.5 Key Findings and Opportunity Assessment
6.5.1 Key Findings
6.5.2 Opportunity Assessment
6.6 Market Dynamics
6.6.1 Overview
6.6.2 Impact Analysis
6.6.3 Market Drivers
6.6.3.1 Increasing Installed Bases of Radiology Equipment and Number of Scans
6.6.3.2 Growing Geriatric Population
6.6.3.3 Increasing Prevalence of Chronic and Lifestyle-Associated Diseases
6.6.3.3.1 Increasing Prevalence of Cancer
6.6.3.3.2 Increasing Prevalence of Cardiovascular Diseases
6.6.3.3.3 Increasing Prevalence of Respiratory Diseases
6.6.3.4 Increasing Regulatory Requirements for Diagnostic Devices
6.6.3.5 Increasing Concern Related to Radiation Over Exposure
6.6.3.6 Growing Awareness and Initiatives for Radiation Dose Management
6.6.4 Market Restraints
6.6.4.1 Lack of Skilled and Trained Professionals
6.6.4.2 High Cost Associated with Radiation Dose Software
6.6.5 Opportunities
6.6.5.1 Innovation
6.6.5.1.1 Technological Advancements in Medical Imaging
6.6.5.1.2 Impact of Cloud-Based Solutions
6.6.5.2 Regulatory Focus on Pediatric Procedures
6.6.5.2.1 Radiation Dose Management for Pediatric Procedures
6.6.5.3 Regional Expansion and Increasing Adoption of Radiation Dose Management Software in Emerging Economies
7 COMPETITIVE LANDSCAPE
7.1 Key Developments and Strategies
7.1.1 Collaborations, Agreements, and Partnerships
7.1.2 Product Launches
7.1.3 Regulatory Approvals
7.1.4 Mergers and Acquisitions
7.2 Market Share Analysis
7.2.1 Market Share Analysis, by Company
8 RADIATION DOSE MANAGEMENT PRICING ANALYSIS
8.1 Manual Dose Data Recording Cost Per Examination
8.2 Radiation Dose Management Software Pricing
8.3 Server Fee
9 INDUSTRY INSIGHTS
9.1 Patent Analysis
9.1.1 Patent Analysis (by Modality Type)
9.2 Regulatory Requirements
9.3 Bills and Acts for Radiation Dose Management
9.4 Alliances
9.5 Associations and Consortiums
10 GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY MODALITY)
10.1 CT Scanners
10.2 X-Ray, CR, and DR
10.3 Mammography System
10.4 Interventional Angiography Systems/Angio CT
10.5 Fluoroscopy Systems
10.6 PET Scanners and SPECT
10.7 Hybrid Imaging
11 GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY PRODUCT)
11.1 Introduction
11.2 Radimetrics Enterprise Platform
11.2.1 Key Features
11.2.2 Radimetrics Enterprise Platform- Global Market
11.2.3 Installed Base and Number of Customers
11.2.4 Compatible Modalities
11.2.5 Competitive Benchmarking
11.3 DoseWatch and Dose Watch Explorer
11.3.1 Key Features
11.3.2 DoseWatch and DoseWatch Explorer- Global Market
11.3.3 Installed Base and Number of Customers
11.3.4 Compatible Modalities
11.3.5 Competitive Benchmarking
11.4 teamplay Dose
11.4.1 Key Features
11.4.2 teamplay Dose- Global Market
11.4.3 Installed Base and Number of Customers
11.4.4 Compatible Modalities
11.4.5 Competitive Benchmarking
11.5 NEXO [DOSE]
11.5.1 Key Features
11.5.2 NEXO [DOSE]- Global Market
11.5.3 Installed Base and Number of Customers
11.5.4 Compatible Modalities
11.5.5 Competitive Benchmarking
11.6 tqm/Dose and DoseMonitor
11.6.1 Key Features
11.6.2 tqm/Dose and DoseMonitor- Global Market
11.6.3 Installed Base and Number of Customers
11.6.4 Compatible Modalities
11.6.5 Competitive Benchmarking
11.7 Radiation Dose Monitor
11.7.1 Key Features
11.7.2 Radiation Dose Monitor- Global Market
11.7.3 Installed Base and Number of Customers
11.7.4 Compatible Modalities
11.7.5 Competitive Benchmarking
11.8 Imalogix Platform
11.8.1 Key Features
11.8.2 Imalogix Platform- Global Market
11.8.3 Installed Base and Number of Customers
11.8.4 Compatible Modalities
11.8.5 Competitive Benchmarking
11.9 Syncro-Dose and Aspire AWS
11.9.1 Key Features
11.9.2 Syncro-Dose- Global Market
11.9.3 Installed Base and Number of Customers
11.9.4 Compatible Modalities
11.9.5 Competitive Benchmarking
11.1 NovaDose
11.10.1 Key Features
11.10.2 NovaDose- Global Market
11.10.3 Installed Base and Number of Customers
11.10.4 Compatible Modalities
11.10.5 Competitive Benchmarking
11.11 DoseWise Portal
11.11.1 Key Features
11.11.2 DoseWise Portal- Global Market
11.11.3 Installed Base and Number of Customers
11.11.4 Compatible Modalities
11.11.5 Competitive Benchmarking
11.12 SafeCT
11.12.1 Key Features
11.12.2 SafeCT- Global Market
11.12.3 Installed Base and Number of Customers
11.12.4 Compatible Modalities
11.12.5 Competitive Benchmarking
11.13 MyXrayDose
11.13.1 Key Features
11.13.2 MyXrayDose- Global Market
11.13.3 Installed Base and Number of Customers
11.13.4 Compatible Modalities
11.13.5 Competitive Benchmarking
11.14 DoseM
11.14.1 Key Features
11.14.2 DoseM- Global Market
11.14.3 Installed Base and Number of Customers
11.14.4 Compatible Modalities
11.14.5 Competitive Benchmarking
11.15 Dose Tracking System
11.15.1 Key Features
11.15.2 Dose Tracking System- Global Market
11.15.3 Installed Base and Number of Customers
11.15.4 Compatible Modalities
11.15.5 Competitive Benchmarking
11.16 DoseTrack
11.16.1 Key Features
11.16.2 DoseTrack- Global Market
11.16.3 Installed Base and Number of Customers
11.16.4 Compatible Modalities
11.16.5 Competitive Benchmarking
12 GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY MODE OF DEPLOYMENT)
12.1 Introduction
12.2 Competitive Benchmarking
12.3 Web-Based
12.4 On-Premises
12.5 Cloud-Based
13 GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY END USERS)
13.1 Introduction
13.2 Hospital
13.3 Diagnostic Centers
13.4 Others
14 GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY REGION)
14.1 North America Radiation Dose Management Market
14.1.1 North America: Radiation Dose Management Market (by Modality)
14.1.2 North America: Radiation Dose Management (by End User)
14.1.3 North America Radiation Dose Management Market (by Country)
14.1.3.1 U.S.
14.1.3.1.1 U.S. Radiation Dose Management (by End User)
14.1.3.2 Canada
14.1.3.2.1 Canada Radiation Dose Management (by End User)
14.1.4 Regulation
14.1.5 Developments
14.2 Europe
14.2.1 Europe Radiation Dose Management Market (by Modality)
14.2.2 Europe Radiation Dose Management (by End User)
14.2.3 Europe Radiation Dose Management Market (by Country)
14.2.3.1 Germany
14.2.3.1.1 Germany Radiation Dose Management (by End User)
14.2.3.2 France
14.2.3.2.1 France Radiation Dose Management (by End User)
14.2.3.3 Italy
14.2.3.3.1 Italy Radiation Dose Management (by End User)
14.2.3.4 U.K.
14.2.3.4.1 U.K. Radiation Dose Management (by End User)
14.2.3.5 Spain
14.2.3.5.1 Spain Radiation Dose Management (by End User)
14.2.3.6 Netherlands
14.2.3.6.1 Netherlands Radiation Dose Management (by End User)
14.2.3.7 Russia
14.2.3.7.1 Russia Radiation Dose Management (by End User)
14.2.3.8 Rest-of-Europe
14.2.3.9 Rest-of-Europe Radiation Dose Management (by End User)
14.2.4 Regulation
14.2.5 Developments
14.3 Asia-Pacific Radiation Dose Management Market
14.3.1 Asia-Pacific Radiation Dose Management Market (by Modality)
14.3.2 Asia-Pacific Radiation Dose Management (by End User)
14.3.3 Asia-Pacific Radiation Dose Management Market (by Country)
14.3.3.1 Japan
14.3.3.1.1 Japan Radiation Dose Management (by End User)
14.3.3.2 China
14.3.3.2.1 China Radiation Dose Management (by End User)
14.3.3.3 Australia and New Zealand
14.3.3.3.1 Australia and New Zealand Radiation Dose Management (by End User)
14.3.3.4 South Korea
14.3.3.4.1 South Korea Radiation Dose Management (by End User)
14.3.3.5 India
14.3.3.5.1 India Radiation Dose Management (by End User)
14.3.3.6 Rest-of-Asia-Pacific
14.3.3.6.1 Rest of Asia-Pacific Radiation Dose Management (by End User)
14.3.4 Regulations
14.3.5 Developments
14.4 Latin America
14.4.1 Latin America Radiation Dose Management Market (by Modality)
14.4.2 Latin America Radiation Dose Management (by End User)
14.4.3 Latin America Radiation Dose Management Market (by Country)
14.4.3.1 Brazil
14.4.3.2 Brazil Radiation Dose Management (by End User)
14.4.3.3 Mexico
14.4.3.3.1 Mexico Radiation Dose Management (by End User)
14.4.3.4 Rest-of-Latin America
14.4.3.4.1 Rest-of-Latin America Radiation Dose Management (by End User)
14.4.4 Regulations
14.5 Rest-of-the-World
14.5.1 Rest-of-the-World Radiation Dose Management Market (by Modality)
14.5.2 Rest-of-the-World Radiation Dose Management (by End User)
14.5.3 Rest-of-the-World Radiation Dose Management Market (by Country)
14.5.3.1 Middle East
14.5.3.1.1 Middle East Radiation Dose Management (by End User)
14.5.3.2 Africa
14.5.3.2.1 Africa Radiation Dose Management (by End User)
14.5.4 Regulations
15 COMPANY PROFILES
15.1 Agfa-Gevaert Group
15.1.1 Company Overview
15.1.2 Role of Agfa Gevaert Group in the Radiation Dose Management Market
15.1.3 Financials
15.1.4 Recent Development
15.1.5 SWOT Analysis
15.2 Bayer AG
15.2.1 Company Overview
15.2.2 Role of Bayer AG in the Radiation Dose Management Market
15.2.3 Financials
15.2.4 Recent Development
15.2.5 SWOT Analysis
15.3 Bracco
15.3.1 Company Overview
15.3.2 Role of Bracco in the Radiation Dose Management Market
15.3.3 Recent Development
15.3.4 SWOT Analysis
15.4 Canon Inc.
15.4.1 Company Overview
15.4.2 Role of Canon Inc. in the Radiation Dose Management Market
15.4.3 Financials
15.4.4 Recent Development
15.4.5 SWOT Analysis
15.5 Fujifilm Holdings Corporation
15.5.1 Company Overview
15.5.2 Role of Fujifilm Holdings Corporation in the Radiation Dose Management Market
15.5.3 Financials
15.5.4 SWOT Analysis
15.6 Guerbet Group
15.6.1 Company Overview
15.6.2 Role of Guerbet LLC in the Radiation Dose Management Market
15.6.3 Financials
15.6.4 Recent Development
15.6.5 SWOT Analysis
15.7 General Electric Company
15.7.1 Company Overview
15.7.2 Role of General Electric Company in Radiation Dose Management Market
15.7.3 Financials
15.7.4 Recent Development
15.7.5 SWOT Analysis
15.8 Imalogix
15.8.1 Company Overview
15.8.2 Role of Imalogix in the Radiation Dose Management Market
15.8.3 Recent Development
15.8.4 SWOT Analysis
15.9 Infinitt Healthcare Co., Ltd.
15.9.1 Company Overview
15.9.2 Role of Infinitt Healthcare Co., Ltd. in the Radiation Dose Management Market
15.9.3 Recent Development
15.9.4 SWOT Analysis
15.1 Koninklijke Philips N.V.
15.10.1 Company Overview
15.10.2 Role of Koninklijke Philips N.V. in the Radiation Dose Management Market
15.10.3 Financials
15.10.4 Recent Development
15.10.5 SWOT Analysis
15.11 Medic Vision Imaging Solutions Ltd.
15.11.1 Company Overview
15.11.2 Role of Medic Vision Imaging Solutions Ltd. in the Radiation Dose Management Market
15.11.3 Recent Development
15.11.4 SWOT Analysis
15.12 Medsquare
15.12.1 Company Overview
15.12.2 Role of Medsquare in the Radiation Dose Management Market
15.12.3 Recent Development
15.12.4 SWOT Analysis
15.13 MyXrayDose Ltd.
15.13.1 Company Overview
15.13.2 Role of MyXrayDose Ltd. in the Radiation Dose Management Market
15.13.3 SWOT Analysis
15.14 Novarad Corporation
15.14.1 Company Overview
15.14.2 Role of Novarad Corporation in the Radiation Dose Management Market
15.14.3 Recent Development
15.14.4 SWOT Analysis
15.15 PACSHealth, LLC
15.15.1 Company Overview
15.15.2 Role of PACSHealth LLC in the Radiation Dose Management Market
15.15.3 Recent Development
15.15.4 SWOT Analysis
15.16 Qaelum NV
15.16.1 Company Overview
15.16.2 Role of Qaelum NV in the Radiation Dose Management Market
15.16.3 Recent Development
15.16.4 SWOT Analysis
15.17 Sectra AB
15.17.1 Company Overview
15.17.2 Role of Sectra AB in the Radiation Dose Management Market
15.17.3 Financials
15.17.4 Recent Development
15.17.5 SWOT Analysis
15.18 SST Group Inc.
15.18.1 Company Overview
15.18.2 Role of SST Group Inc. in the Radiation Dose Management Market
15.18.3 Recent Development
15.18.4 SWOT Analysis
15.19 Siemens Healthineers, Inc.
15.19.1 Company Overview
15.19.2 Role of Siemens Healthineers, Inc. in the Radiation Dose Management Market
15.19.3 Financials
15.19.4 Recent Development
15.19.5 SWOT Analysis
15.2 Virtual Phantom, Inc.
15.20.1 Company Overview
15.20.2 Role of Virtual Phantom, Inc. in the Radiation Dose Management Market
15.20.3 Key Developments
15.20.4 SWOT Analysis
1 MARKET OVERVIEW
1.1 Introduction
1.1.1 Natural Radiation Sources
1.1.2 Biological Effects of Radiation
1.1.3 Usage of Radiation in Medical Devices
1.1.4 Radiation Dose
1.1.5 Effective Radiation Dose
1.1.6 Factors Contributing to Unnecessary Radiation Exposure
2 PRODUCT DEFINITION
3 SCOPE OF RESEARCH STUDY
3.1 Scope of the Study
3.2 Exclusion Criteria of the Report
3.3 Key Questions Answered in the Report
3.4 Forecast Period Selection Criteria
4 RESEARCH SCOPE AND METHODOLOGY
4.1 Research Methodology
4.2 Primary Data Sources
4.3 Secondary Data Sources
4.4 Data and Prediction Modeling
4.5 Selection Criteria for Company Profiles
4.6 Brief Overview of Market Estimation Process
4.7 Data Validation
4.8 Assumptions and Limitations
5 COVID-19 IMPACT ANALYSIS
5.1 Impact on Radiation Diagnostic Industry
5.1.1 Industry Analysis
5.1.2 Long-, Mid-, and Short-Term Impact
5.1.3 Impact on Radiation Diagnostic Equipment (CT Scanners, X-Ray, Mammography System, PET Scanners and SPECT, and Others)
5.2 Trend Analysis for Radiation Dose Management Market
5.2.1 Pre-COVID-19
5.2.2 Post-COVID-19
5.3 Regional Impact of COVID-19 Industry
5.3.1 North America
5.3.2 Europe
5.3.3 Asia-Pacific
5.3.4 Rest-of-the-World
5.4 Change in Competitive Landscape and Product Demand
5.5 Emerging Opportunities due to COVID-19 in Radiation Dose Management
5.6 Future Prospective: Post COVID-19 Scenarios and Recommendations
6 GLOBAL RADIATION DOSE MANAGEMENT MARKET SCENARIO
6.1 Historical Trends
6.2 Trends for Radiation Dose Management
6.3 Global Radiation Dose Management Scenario
6.4 Assumptions and Limitations
6.5 Key Findings and Opportunity Assessment
6.5.1 Key Findings
6.5.2 Opportunity Assessment
6.6 Market Dynamics
6.6.1 Overview
6.6.2 Impact Analysis
6.6.3 Market Drivers
6.6.3.1 Increasing Installed Bases of Radiology Equipment and Number of Scans
6.6.3.2 Growing Geriatric Population
6.6.3.3 Increasing Prevalence of Chronic and Lifestyle-Associated Diseases
6.6.3.3.1 Increasing Prevalence of Cancer
6.6.3.3.2 Increasing Prevalence of Cardiovascular Diseases
6.6.3.3.3 Increasing Prevalence of Respiratory Diseases
6.6.3.4 Increasing Regulatory Requirements for Diagnostic Devices
6.6.3.5 Increasing Concern Related to Radiation Over Exposure
6.6.3.6 Growing Awareness and Initiatives for Radiation Dose Management
6.6.4 Market Restraints
6.6.4.1 Lack of Skilled and Trained Professionals
6.6.4.2 High Cost Associated with Radiation Dose Software
6.6.5 Opportunities
6.6.5.1 Innovation
6.6.5.1.1 Technological Advancements in Medical Imaging
6.6.5.1.2 Impact of Cloud-Based Solutions
6.6.5.2 Regulatory Focus on Pediatric Procedures
6.6.5.2.1 Radiation Dose Management for Pediatric Procedures
6.6.5.3 Regional Expansion and Increasing Adoption of Radiation Dose Management Software in Emerging Economies
7 COMPETITIVE LANDSCAPE
7.1 Key Developments and Strategies
7.1.1 Collaborations, Agreements, and Partnerships
7.1.2 Product Launches
7.1.3 Regulatory Approvals
7.1.4 Mergers and Acquisitions
7.2 Market Share Analysis
7.2.1 Market Share Analysis, by Company
8 RADIATION DOSE MANAGEMENT PRICING ANALYSIS
8.1 Manual Dose Data Recording Cost Per Examination
8.2 Radiation Dose Management Software Pricing
8.3 Server Fee
9 INDUSTRY INSIGHTS
9.1 Patent Analysis
9.1.1 Patent Analysis (by Modality Type)
9.2 Regulatory Requirements
9.3 Bills and Acts for Radiation Dose Management
9.4 Alliances
9.5 Associations and Consortiums
10 GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY MODALITY)
10.1 CT Scanners
10.2 X-Ray, CR, and DR
10.3 Mammography System
10.4 Interventional Angiography Systems/Angio CT
10.5 Fluoroscopy Systems
10.6 PET Scanners and SPECT
10.7 Hybrid Imaging
11 GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY PRODUCT)
11.1 Introduction
11.2 Radimetrics Enterprise Platform
11.2.1 Key Features
11.2.2 Radimetrics Enterprise Platform- Global Market
11.2.3 Installed Base and Number of Customers
11.2.4 Compatible Modalities
11.2.5 Competitive Benchmarking
11.3 DoseWatch and Dose Watch Explorer
11.3.1 Key Features
11.3.2 DoseWatch and DoseWatch Explorer- Global Market
11.3.3 Installed Base and Number of Customers
11.3.4 Compatible Modalities
11.3.5 Competitive Benchmarking
11.4 teamplay Dose
11.4.1 Key Features
11.4.2 teamplay Dose- Global Market
11.4.3 Installed Base and Number of Customers
11.4.4 Compatible Modalities
11.4.5 Competitive Benchmarking
11.5 NEXO [DOSE]
11.5.1 Key Features
11.5.2 NEXO [DOSE]- Global Market
11.5.3 Installed Base and Number of Customers
11.5.4 Compatible Modalities
11.5.5 Competitive Benchmarking
11.6 tqm/Dose and DoseMonitor
11.6.1 Key Features
11.6.2 tqm/Dose and DoseMonitor- Global Market
11.6.3 Installed Base and Number of Customers
11.6.4 Compatible Modalities
11.6.5 Competitive Benchmarking
11.7 Radiation Dose Monitor
11.7.1 Key Features
11.7.2 Radiation Dose Monitor- Global Market
11.7.3 Installed Base and Number of Customers
11.7.4 Compatible Modalities
11.7.5 Competitive Benchmarking
11.8 Imalogix Platform
11.8.1 Key Features
11.8.2 Imalogix Platform- Global Market
11.8.3 Installed Base and Number of Customers
11.8.4 Compatible Modalities
11.8.5 Competitive Benchmarking
11.9 Syncro-Dose and Aspire AWS
11.9.1 Key Features
11.9.2 Syncro-Dose- Global Market
11.9.3 Installed Base and Number of Customers
11.9.4 Compatible Modalities
11.9.5 Competitive Benchmarking
11.1 NovaDose
11.10.1 Key Features
11.10.2 NovaDose- Global Market
11.10.3 Installed Base and Number of Customers
11.10.4 Compatible Modalities
11.10.5 Competitive Benchmarking
11.11 DoseWise Portal
11.11.1 Key Features
11.11.2 DoseWise Portal- Global Market
11.11.3 Installed Base and Number of Customers
11.11.4 Compatible Modalities
11.11.5 Competitive Benchmarking
11.12 SafeCT
11.12.1 Key Features
11.12.2 SafeCT- Global Market
11.12.3 Installed Base and Number of Customers
11.12.4 Compatible Modalities
11.12.5 Competitive Benchmarking
11.13 MyXrayDose
11.13.1 Key Features
11.13.2 MyXrayDose- Global Market
11.13.3 Installed Base and Number of Customers
11.13.4 Compatible Modalities
11.13.5 Competitive Benchmarking
11.14 DoseM
11.14.1 Key Features
11.14.2 DoseM- Global Market
11.14.3 Installed Base and Number of Customers
11.14.4 Compatible Modalities
11.14.5 Competitive Benchmarking
11.15 Dose Tracking System
11.15.1 Key Features
11.15.2 Dose Tracking System- Global Market
11.15.3 Installed Base and Number of Customers
11.15.4 Compatible Modalities
11.15.5 Competitive Benchmarking
11.16 DoseTrack
11.16.1 Key Features
11.16.2 DoseTrack- Global Market
11.16.3 Installed Base and Number of Customers
11.16.4 Compatible Modalities
11.16.5 Competitive Benchmarking
12 GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY MODE OF DEPLOYMENT)
12.1 Introduction
12.2 Competitive Benchmarking
12.3 Web-Based
12.4 On-Premises
12.5 Cloud-Based
13 GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY END USERS)
13.1 Introduction
13.2 Hospital
13.3 Diagnostic Centers
13.4 Others
14 GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY REGION)
14.1 North America Radiation Dose Management Market
14.1.1 North America: Radiation Dose Management Market (by Modality)
14.1.2 North America: Radiation Dose Management (by End User)
14.1.3 North America Radiation Dose Management Market (by Country)
14.1.3.1 U.S.
14.1.3.1.1 U.S. Radiation Dose Management (by End User)
14.1.3.2 Canada
14.1.3.2.1 Canada Radiation Dose Management (by End User)
14.1.4 Regulation
14.1.5 Developments
14.2 Europe
14.2.1 Europe Radiation Dose Management Market (by Modality)
14.2.2 Europe Radiation Dose Management (by End User)
14.2.3 Europe Radiation Dose Management Market (by Country)
14.2.3.1 Germany
14.2.3.1.1 Germany Radiation Dose Management (by End User)
14.2.3.2 France
14.2.3.2.1 France Radiation Dose Management (by End User)
14.2.3.3 Italy
14.2.3.3.1 Italy Radiation Dose Management (by End User)
14.2.3.4 U.K.
14.2.3.4.1 U.K. Radiation Dose Management (by End User)
14.2.3.5 Spain
14.2.3.5.1 Spain Radiation Dose Management (by End User)
14.2.3.6 Netherlands
14.2.3.6.1 Netherlands Radiation Dose Management (by End User)
14.2.3.7 Russia
14.2.3.7.1 Russia Radiation Dose Management (by End User)
14.2.3.8 Rest-of-Europe
14.2.3.9 Rest-of-Europe Radiation Dose Management (by End User)
14.2.4 Regulation
14.2.5 Developments
14.3 Asia-Pacific Radiation Dose Management Market
14.3.1 Asia-Pacific Radiation Dose Management Market (by Modality)
14.3.2 Asia-Pacific Radiation Dose Management (by End User)
14.3.3 Asia-Pacific Radiation Dose Management Market (by Country)
14.3.3.1 Japan
14.3.3.1.1 Japan Radiation Dose Management (by End User)
14.3.3.2 China
14.3.3.2.1 China Radiation Dose Management (by End User)
14.3.3.3 Australia and New Zealand
14.3.3.3.1 Australia and New Zealand Radiation Dose Management (by End User)
14.3.3.4 South Korea
14.3.3.4.1 South Korea Radiation Dose Management (by End User)
14.3.3.5 India
14.3.3.5.1 India Radiation Dose Management (by End User)
14.3.3.6 Rest-of-Asia-Pacific
14.3.3.6.1 Rest of Asia-Pacific Radiation Dose Management (by End User)
14.3.4 Regulations
14.3.5 Developments
14.4 Latin America
14.4.1 Latin America Radiation Dose Management Market (by Modality)
14.4.2 Latin America Radiation Dose Management (by End User)
14.4.3 Latin America Radiation Dose Management Market (by Country)
14.4.3.1 Brazil
14.4.3.2 Brazil Radiation Dose Management (by End User)
14.4.3.3 Mexico
14.4.3.3.1 Mexico Radiation Dose Management (by End User)
14.4.3.4 Rest-of-Latin America
14.4.3.4.1 Rest-of-Latin America Radiation Dose Management (by End User)
14.4.4 Regulations
14.5 Rest-of-the-World
14.5.1 Rest-of-the-World Radiation Dose Management Market (by Modality)
14.5.2 Rest-of-the-World Radiation Dose Management (by End User)
14.5.3 Rest-of-the-World Radiation Dose Management Market (by Country)
14.5.3.1 Middle East
14.5.3.1.1 Middle East Radiation Dose Management (by End User)
14.5.3.2 Africa
14.5.3.2.1 Africa Radiation Dose Management (by End User)
14.5.4 Regulations
15 COMPANY PROFILES
15.1 Agfa-Gevaert Group
15.1.1 Company Overview
15.1.2 Role of Agfa Gevaert Group in the Radiation Dose Management Market
15.1.3 Financials
15.1.4 Recent Development
15.1.5 SWOT Analysis
15.2 Bayer AG
15.2.1 Company Overview
15.2.2 Role of Bayer AG in the Radiation Dose Management Market
15.2.3 Financials
15.2.4 Recent Development
15.2.5 SWOT Analysis
15.3 Bracco
15.3.1 Company Overview
15.3.2 Role of Bracco in the Radiation Dose Management Market
15.3.3 Recent Development
15.3.4 SWOT Analysis
15.4 Canon Inc.
15.4.1 Company Overview
15.4.2 Role of Canon Inc. in the Radiation Dose Management Market
15.4.3 Financials
15.4.4 Recent Development
15.4.5 SWOT Analysis
15.5 Fujifilm Holdings Corporation
15.5.1 Company Overview
15.5.2 Role of Fujifilm Holdings Corporation in the Radiation Dose Management Market
15.5.3 Financials
15.5.4 SWOT Analysis
15.6 Guerbet Group
15.6.1 Company Overview
15.6.2 Role of Guerbet LLC in the Radiation Dose Management Market
15.6.3 Financials
15.6.4 Recent Development
15.6.5 SWOT Analysis
15.7 General Electric Company
15.7.1 Company Overview
15.7.2 Role of General Electric Company in Radiation Dose Management Market
15.7.3 Financials
15.7.4 Recent Development
15.7.5 SWOT Analysis
15.8 Imalogix
15.8.1 Company Overview
15.8.2 Role of Imalogix in the Radiation Dose Management Market
15.8.3 Recent Development
15.8.4 SWOT Analysis
15.9 Infinitt Healthcare Co., Ltd.
15.9.1 Company Overview
15.9.2 Role of Infinitt Healthcare Co., Ltd. in the Radiation Dose Management Market
15.9.3 Recent Development
15.9.4 SWOT Analysis
15.1 Koninklijke Philips N.V.
15.10.1 Company Overview
15.10.2 Role of Koninklijke Philips N.V. in the Radiation Dose Management Market
15.10.3 Financials
15.10.4 Recent Development
15.10.5 SWOT Analysis
15.11 Medic Vision Imaging Solutions Ltd.
15.11.1 Company Overview
15.11.2 Role of Medic Vision Imaging Solutions Ltd. in the Radiation Dose Management Market
15.11.3 Recent Development
15.11.4 SWOT Analysis
15.12 Medsquare
15.12.1 Company Overview
15.12.2 Role of Medsquare in the Radiation Dose Management Market
15.12.3 Recent Development
15.12.4 SWOT Analysis
15.13 MyXrayDose Ltd.
15.13.1 Company Overview
15.13.2 Role of MyXrayDose Ltd. in the Radiation Dose Management Market
15.13.3 SWOT Analysis
15.14 Novarad Corporation
15.14.1 Company Overview
15.14.2 Role of Novarad Corporation in the Radiation Dose Management Market
15.14.3 Recent Development
15.14.4 SWOT Analysis
15.15 PACSHealth, LLC
15.15.1 Company Overview
15.15.2 Role of PACSHealth LLC in the Radiation Dose Management Market
15.15.3 Recent Development
15.15.4 SWOT Analysis
15.16 Qaelum NV
15.16.1 Company Overview
15.16.2 Role of Qaelum NV in the Radiation Dose Management Market
15.16.3 Recent Development
15.16.4 SWOT Analysis
15.17 Sectra AB
15.17.1 Company Overview
15.17.2 Role of Sectra AB in the Radiation Dose Management Market
15.17.3 Financials
15.17.4 Recent Development
15.17.5 SWOT Analysis
15.18 SST Group Inc.
15.18.1 Company Overview
15.18.2 Role of SST Group Inc. in the Radiation Dose Management Market
15.18.3 Recent Development
15.18.4 SWOT Analysis
15.19 Siemens Healthineers, Inc.
15.19.1 Company Overview
15.19.2 Role of Siemens Healthineers, Inc. in the Radiation Dose Management Market
15.19.3 Financials
15.19.4 Recent Development
15.19.5 SWOT Analysis
15.2 Virtual Phantom, Inc.
15.20.1 Company Overview
15.20.2 Role of Virtual Phantom, Inc. in the Radiation Dose Management Market
15.20.3 Key Developments
15.20.4 SWOT Analysis
LIST OF TABLES
Table 1: Impact Analysis of Market Drivers and Restraints
Table 2: Company Distribution Based on Mode of Deployment
Table 1.1: Effective Radiation Dose for Adults for Radiology Procedures
Table 5.1: Vaccines Approved for COVID-19
Table 5.2: Imaging Procedures in 2020 and 2019 by Patient Service Locations, New York
Table 5.3: Imaging Procedures in 2020 and 2019 by Imaging Modality Types, New York
Table 5.4: COVID-19 Vaccines Granted for Emergency Use in North America
Table 5.5: Healthcare Expenditure During FY2020 Across Various Regions in Europe
Table 5.6: COVID-19 Vaccines Granted for Emergency Use in Europe
Table 5.7: COVID-19 Vaccines Granted for Emergency Use in Asia-Pacific
Table 5.8: COVID-19 Vaccines Granted for Emergency Use in Rest-of-the-World
Table 6.1: Impact Analysis of Market Drivers and Restraints
Table 9.1: Global Radiation Dose Management System Patent Technology and Their Application
Table 9.2: List of Major Regulatory Bodies
Table 9.3: Some of the Bills and Acts for Radiation Dose Management
Table 9.4: Some of the Alliances for Radiation Dose Management
Table 9.5: Associations/Consortiums of the Global Radiation Dose Management Market
Table 10.1: Effective Radiation Dose from Diagnostic CT Procedure
Table 10.2: Effective Price Range of CT Scan in Different States in the U.S. for CT Scans
Table 10.3: Effective Radiation Dose from Diagnostic X-Ray-Single Exposure
Table 11.1: Competitive Benchmarking
Table 11.2: Competitive Benchmarking
Table 11.3: Competitive Benchmarking
Table 11.4: Competitive Benchmarking
Table 11.5: Competitive Benchmarking
Table 11.6: Competitive Benchmarking
Table 11.7: Competitive Benchmarking
Table 11.8: Competitive Benchmarking
Table 11.9: Competitive Benchmarking
Table 11.10: Competitive Benchmarking
Table 11.11: Competitive Benchmarking
Table 11.12: Competitive Benchmarking
Table 11.13: Competitive Benchmarking
Table 11.14: Competitive Benchmarking
Table 11.15: Competitive Benchmarking
Table 12.1: Competitive Benchmarking on the basis of Mode of Deployment
Table 14.1: Number of Cases of Cancer Latin America, 2020
Table 14.2: Number of Cases of Cancer in Brazil, 2020
Table 14.3: Number of Cases of Cancer in Mexico, 2020
Table 1: Impact Analysis of Market Drivers and Restraints
Table 2: Company Distribution Based on Mode of Deployment
Table 1.1: Effective Radiation Dose for Adults for Radiology Procedures
Table 5.1: Vaccines Approved for COVID-19
Table 5.2: Imaging Procedures in 2020 and 2019 by Patient Service Locations, New York
Table 5.3: Imaging Procedures in 2020 and 2019 by Imaging Modality Types, New York
Table 5.4: COVID-19 Vaccines Granted for Emergency Use in North America
Table 5.5: Healthcare Expenditure During FY2020 Across Various Regions in Europe
Table 5.6: COVID-19 Vaccines Granted for Emergency Use in Europe
Table 5.7: COVID-19 Vaccines Granted for Emergency Use in Asia-Pacific
Table 5.8: COVID-19 Vaccines Granted for Emergency Use in Rest-of-the-World
Table 6.1: Impact Analysis of Market Drivers and Restraints
Table 9.1: Global Radiation Dose Management System Patent Technology and Their Application
Table 9.2: List of Major Regulatory Bodies
Table 9.3: Some of the Bills and Acts for Radiation Dose Management
Table 9.4: Some of the Alliances for Radiation Dose Management
Table 9.5: Associations/Consortiums of the Global Radiation Dose Management Market
Table 10.1: Effective Radiation Dose from Diagnostic CT Procedure
Table 10.2: Effective Price Range of CT Scan in Different States in the U.S. for CT Scans
Table 10.3: Effective Radiation Dose from Diagnostic X-Ray-Single Exposure
Table 11.1: Competitive Benchmarking
Table 11.2: Competitive Benchmarking
Table 11.3: Competitive Benchmarking
Table 11.4: Competitive Benchmarking
Table 11.5: Competitive Benchmarking
Table 11.6: Competitive Benchmarking
Table 11.7: Competitive Benchmarking
Table 11.8: Competitive Benchmarking
Table 11.9: Competitive Benchmarking
Table 11.10: Competitive Benchmarking
Table 11.11: Competitive Benchmarking
Table 11.12: Competitive Benchmarking
Table 11.13: Competitive Benchmarking
Table 11.14: Competitive Benchmarking
Table 11.15: Competitive Benchmarking
Table 12.1: Competitive Benchmarking on the basis of Mode of Deployment
Table 14.1: Number of Cases of Cancer Latin America, 2020
Table 14.2: Number of Cases of Cancer in Brazil, 2020
Table 14.3: Number of Cases of Cancer in Mexico, 2020
LIST OF FIGURES
Figure 1: Global Radiation Dose Management Market Value, 2019-2030
Figure 2: Radiation Dose Management Market, Pre-COVID-19 and Post-COVID-19 Scenario, $Million
Figure 3: Dominating Segments of Global Radiation Dose Management Market, 2020 and 2030
Figure 4: Global Radiation Dose Management Market (by Modality), Share Analysis, 2020-2030
Figure 5: Global Radiation Dose Management Market (by Mode of Deployment), Share Analysis, 2020 and 2030
Figure 6: Global Radiation Dose Management Market (by End Users), Share Analysis, 2020 and 2030
Figure 7: Global Radiation Dose Management Market (by Region), 2020
Figure 8: Key Strategies Incorporated by the Key Players in the Radiation Dose Management Market (January 2012–November 2020)
Figure 9: Market Share Analysis for the Global Radiation Dose Management Market (by Company), 2019
Figure 1.1: Sources of Radiation Exposure in the U.S.
Figure 1.2: Dose From Natural Background Radiation (mSv)
Figure 1.3: Different Types of Radiation Doses
Figure 3.1: Global Radiation Dose Management: Market Segmentation
Figure 4.1: Radiation Dose Management Market Research Methodology
Figure 4.2: Primary Research
Figure 4.3: Secondary Research
Figure 4.4: Considered Factors for Data Prediction and Modeling
Figure 4.5: Total Number of Companies Profiled
Figure 4.6: Assumptions and Limitations
Figure 5.1: Long-, Mid-, and Short-Term Impact of COVID-19 on Radiation Dose Management Market
Figure 5.2: Number of Scans by Imaging Modalities in the U.K. from January 2020– May 2020
Figure 5.3: Radiation Dose Management Market, Pre-COVID-19 and Post-COVID-19 Scenarios, $Million
Figure 5.4: Product Demand for Radiation Dose Management Software
Figure 5.5: Various Technological Opportunity Came During COVID-19
Figure 5.6: Recommendations for Hospitals to Optimize the Radiation Dose Process
Figure 6.1: Historic Evolution of X-Rays
Figure 6.2: Historical Evolution of Radiation Dose Management Software
Figure 6.3: Global Radiation Dose Management Market, 2019-2030
Figure 6.4: Market Dynamics
Figure 6.5: Number of Scans by Imaging Modalities in the U.K. From 2015-16 to 2019-20
Figure 6.6: Geriatric Population (60 Years and Above) Worldwide in Different Regions, 2000, 2015, 2030, and 2050
Figure 6.7: Number of Incidence Cases of Cancer in 2018 and 2040
Figure 6.8: Regulatory Bodies for Radiology Diagnostic Devices
Figure 6.9: Major Concerns Related to Overexposure of Radiation in Medical Imaging Devices and Procedures
Figure 7.1: Share of Key Developments and Strategies, January 2012–November 2020
Figure 7.2: Collaborations, Agreements, and Partnerships (by Company), January 2012–November 2020
Figure 7.3: Product Launches and Approvals (by Company), January 2012– November 2020
Figure 7.4: Regulatory Approvals (by Company), January 2012–November 2020
Figure 7.5: Mergers and Acquisitions (by Company), January 2012–November 2020
Figure 7.6: Market Share Analysis for the Global Radiation Dose Management Market (by Company), 2019
Figure 9.1: Patent Segmentation, by Year
Figure 9.2: Patent Segmentation, by Country
Figure 9.3: Patent Segmentation, by Modality
Figure 9.4: Patent Segmentation, by Modality Type
Figure 10.1: Segmentation of Radiation Dose Management Market, by Modality
Figure 10.2: Global Radiation Dose Management Market (by Modality), Market Share, 2020
Figure 10.3: Global Radiation Dose Management Market (by Modality), 2019-2030
Figure 10.4: Benefits of the CT scan
Figure 10.5: CT Scanner in the Global Radiation Dose Management Market, 2019-2030
Figure 10.6: CT Scanners Radiation Dose Management Market (by Region), 2019-2030
Figure 10.7: X-Ray, CR, and DR in the Global Radiation Dose Management Market, 2019-2030
Figure 10.8: X-Ray, CR, and DR Radiation Dose Management Market (by Region), 2019-2030
Figure 10.9: Mammography Systems in the Global Radiation Dose Management Market, 2019-2030
Figure 10.10: Mammography Systems Radiation Dose Management Market (by Region), 2019-2030
Figure 10.11: Interventional Angiography Systems/Angio CT in the Global Radiation Dose Management Market, 2019-2030
Figure 10.12: Interventional Angiography Systems/Angio CT Radiation Dose Management Market (by Region), 2019-2030
Figure 10.13: Benefits of Fluoroscopy System
Figure 10.14: Fluoroscopy Systems in the Global Radiation Dose Management Market, 2019-2030
Figure 10.15: Fluoroscopy Systems Radiation Dose Management Market (by Region), 2019-2030
Figure 10.16: PET Scanners and SPECT in the Global Radiation Dose Management Market, 2019-2030
Figure 10.17: PET Scanners and SPECT Radiation Dose Management Market (by Region), 2019-2030
Figure 10.18: Hybrid Imaging in the Global Radiation Dose Management Market, 2019-2030
Figure 10.19: Hybrid Imaging Radiation Dose Management Market (by Region), 2019-2030
Figure 11.1: Segmentation of Radiation Dose Management Market, (by Product Type)
Figure 11.2: Global Radiation Dose Management Market (by Product Type), 2020 and 2030
Figure 11.3: Global Radiation Dose Management Market (Radimetrics Enterprise Platform), 2019-2030
Figure 11.4: Installed Base and Number of Customers, 2018 and 2019
Figure 11.5: Compatible Modalities of Radimetrics Enterprise Platform
Figure 11.6: Global Radiation Dose Management Market (DoseWatch), 2019-2030
Figure 11.7: Installed Base and Number of Customers, 2018 and 2019
Figure 11.8: Compatible Modalities of DoseWatch
Figure 11.9: Global Radiation Dose Management Market (teamplay Dose), 2019-2030
Figure 11.10: Installed Base and Number of Customers, 2018 and 2019
Figure 11.11: Compatible Modalities of teamplay Dose
Figure 11.12: Global Radiation Dose Management Market (NEXO [DOSE]), 2019-2030
Figure 11.13: Installed Base and Number of Customers, 2018 and 2019
Figure 11.14: Compatible Modalities of NEXO [DOSE]
Figure 11.15: Global Radiation Dose Management Market ( tqm/Dose and DoseMonitor), 2019-2030
Figure 11.16: Installed Base and Number of Customers, 2019 and 2020
Figure 11.17: Compatible Modalities of tqm/Dose and DoseMonitor
Figure 11.18: Global Radiation Dose Management Market (Radiation Dose Monitor), 2019-2030
Figure 11.19: Installed Base and Number of Customers, 2018 and 2019
Figure 11.20: Compatible Modalities of Radiation Dose Monitor
Figure 11.21: Global Radiation Dose Management Market (Imalogix Platform), 2019-2030
Figure 11.22: Installed Base and Number of Customers, 2018 and 2019
Figure 11.23: Compatible Modalities of Imalogix Platform
Figure 11.24: Global Radiation Dose Management Market (Syncro-Dose), 2019-2030
Figure 11.25: Installed Base and Number of Customers, 2018 and 2019
Figure 11.26: Compatible Modalities of Syncro-Dose
Figure 11.27: Global Radiation Dose Management Market (NovaDose), 2019-2030
Figure 11.28: Installed Base and Number of Customers, 2018 and 2019
Figure 11.29: Compatible Modalities of NovaDose
Figure 11.30: Global Radiation Dose Management Market (DoseWise Portal), 2019-2030
Figure 11.31: Installed Base and Number of Customers, 2018 and 2019
Figure 11.32: Compatible Modalities of DoseWise Portal
Figure 11.33: Global Radiation Dose Management Market (SafeCT), 2019-2030
Figure 11.34: Installed Base and Number of Customers, 2018 and 2019
Figure 11.35: Compatible Modalities of SafeCT
Figure 11.36: Global Radiation Dose Management Market (MyXrayDose), 2019-203
Figure 11.37: Installed Base and Number of Customers, 2018 and 2019
Figure 11.38: Compatible Modalities of MyXrayDose
Figure 11.39: Global Radiation Dose Management Market (DoseM), 2019-2030
Figure 11.40: Installed Base and Number of Customers, 2018 and 2019
Figure 11.41: Compatible Modalities of DoseM
Figure 11.42: Global Radiation Dose Management Market (Dose Tracking System), 2019-2030
Figure 11.43: Installed Base and Number of Customers, 2018 and 2019
Figure 11.44: Compatible Modalities of the Dose Tracking System
Figure 11.45: Global Radiation Dose Management Market (DoseTrack), 2019-2030
Figure 11.46: Installed Base and Number of Customers, 2018 and 2019
Figure 11.47: Compatible Modalities of DoseTrack
Figure 12.1: Segmentation of Radiation Dose Management Market (by Mode of Deployment)
Figure 12.2: Global Radiation Dose Management Market (by Mode of Deployment), 2019-2030
Figure 12.3: Global Radiation Dose Management Installed Base (by Mode of Deployment), 2019-2030
Figure 12.4: Global Radiation Dose Management Market (Web-Based), 2019-2030
Figure 12.5: Web-Based Radiation Dose Management Market (by Region), 2019-2030
Figure 12.6: Global Radiation Dose Management Market (On-Premises), 2019-2030
Figure 12.7: On-Premises Radiation Dose Management Market (by Region), 2019-2030
Figure 12.8: Global Radiation Dose Management Market (Cloud-Based), 2019-2030
Figure 12.9: Cloud-Based Radiation Dose Management Market (by Region), 2019-2030
Figure 13.1: Segmentation of Radiation Dose Management Market (by End User)
Figure 13.2: Global Radiation Dose Management Market (by End User), 2020 and 2030
Figure 13.3: Global Radiation Dose Management Market (Hospital), 2019-2030
Figure 13.4: Global Radiation Dose Management Market (Diagnostic Centers), 2019-2030
Figure 13.5: Global Radiation Dose Management Market (by Others), 2019-2030
Figure 14.1: Global Radiation Dose Management Market (by Region), 2020
Figure 14.2: Global Radiation Dose Management Market (by Region), $Million, 2019-2030
Figure 14.3: North America Radiation Dose Management Market, $Million, 2019-2030
Figure 14.4: North America: Market Dynamics
Figure 14.5: North America: Radiation Dose Management Market (by Modality), 2019-2030
Figure 14.6: North America: Radiation Dose Management Market (by End User), 2019-2030
Figure 14.7: North America: Radiation Dose Management Market (by Country), 2020 and 2030
Figure 14.8: Patient Data of New Cancer Cases by Cancer Type in the U.S.(2020)
Figure 14.9: U.S. Radiation Dose Management Market, 2019-2030
Figure 14.10: U.S. Radiation Dose Management Market (by End User), 2019-2030
Figure 14.11: Number of Units of Imaging Devices in Canada in 2017
Figure 14.12: Key Features of Imaging Devices in Canada
Figure 14.13: Canada Radiation Dose Management Market, 2019-2030
Figure 14.14: Canada Radiation Dose Management Market (by End User), 2019-2030
Figure 14.15: Europe Radiation Dose Management Market, 2019-2030
Figure 14.16: Europe Market Dynamics
Figure 14.17: Europe Radiation Dose Management Market (by Modality), 2019-2030
Figure 14.18: Europe Radiation Dose Management Market (by End User), 2019-2030
Figure 14.19: Europe Radiation Dose Management Market (by Country), 2019-2030
Figure 14.20: Germany Radiation Dose Management Market, 2019-2030
Figure 14.21: Germany Radiation Dose Management Market (by End User), 2019-2030
Figure 14.22: France Radiation Dose Management Market, 2019-2030
Figure 14.23: France Radiation Dose Management Market (by End User), 2019-2030
Figure 14.24: Italy Radiation Dose Management Market, 2019-2030
Figure 14.25: Italy Radiation Dose Management Market (by End User), 2019-2030
Figure 14.26: U.K. Radiation Dose Management Market, 2019-2030
Figure 14.27: U.K. Radiation Dose Management Market (by End User), 2019-2030
Figure 14.28: Spain Radiation Dose Management Market, 2019-2030
Figure 14.29: Spain Radiation Dose Management Market (by End User), 2019-2030
Figure 14.30: Netherlands Radiation Dose Management Market, 2019-2030
Figure 14.31: Netherlands Radiation Dose Management Market (by End User), 2019-2030
Figure 14.32: Russia Radiation Dose Management Market, 2019-2030
Figure 14.33: Russia Radiation Dose Management Market (by End User), 2019-2030
Figure 14.34: Rest-of-Europe Radiation Dose Management Market, 2019-2030
Figure 14.35: Rest-of-Europe Radiation Dose Management Market (by End User), 2019-2030
Figure 14.36: Asia-Pacific Radiation Dose Management Market, $Million, 2019-2030
Figure 14.37: Asia-Pacific Market Dynamics
Figure 14.38: Asia-Pacific Radiation Dose Management Market (by Modality), 2019-2030
Figure 14.39: Asia-Pacific Radiation Dose Management Market (by End User), 2019-2030
Figure 14.40: Asia-Pacific Radiation Dose Management Market (by Country), 2019-2030
Figure 14.41: Recommendations by the Science Council of Japan (2017)
Figure 14.42: Japan Radiation Dose Management Market, 2019-2030
Figure 14.43: Japan Radiation Dose Management Market (by End User), 2019-2030
Figure 14.44: China Radiation Dose Management Market, 2019-2030
Figure 14.45: China Radiation Dose Management Market (by End User), 2019-2030
Figure 14.46: Australia and New Zealand Radiation Dose Management Market, 2019-2030
Figure 14.47: Australia and New Zealand Radiation Dose Management Market (by End User), 2019-2030
Figure 14.48: South Korea Radiation Dose Management Market, 2019-2030
Figure 14.49: South Korea Radiation Dose Management Market (by End User), 2019-2030
Figure 14.50: India Radiation Dose Management Market, 2019-2030
Figure 14.51: India Radiation Dose Management Market (by End User), 2019-2030
Figure 14.52: Rest-of-Asia-Pacific Radiation Dose Management Market, 2019-2030
Figure 14.53: Rest of Asia-Pacific Radiation Dose Management Market (by End User), 2019-2030
Figure 14.54: Latin America Radiation Dose Management Market, 2019-2030
Figure 14.55: Latin America Market Dynamics
Figure 14.56: Latin America Radiation Dose Management Market (by Modality), 2019-2030
Figure 14.57: Latin America Radiation Dose Management Market (by End User), 2019-2030
Figure 14.58: Latin America Radiation Dose Management Market (by Country), 2019-2030
Figure 14.59: Brazil Radiation Dose Management Market, 2021-2030
Figure 14.60: Brazil Radiation Dose Management Market (by End User), 2019-2030
Figure 14.61: Mexico Radiation Dose Management Market, 2019-2030
Figure 14.62: Mexico Radiation Dose Management Market (by End User), 2019-2030
Figure 14.63: Rest-of-Latin America Radiation Dose Management Market, 2019-2030
Figure 14.64: Rest-of-Latin America Radiation Dose Management Market (by End User), 2019-2030
Figure 14.65: Rest-of-the-World Radiation Dose Management Market, 2019-2030
Figure 14.66: Middle East and Africa Market Dynamics
Figure 14.67: Rest-of-the-World Radiation Dose Management Market (by Modality), 2019-2030
Figure 14.68: Rest-of-the-World Radiation Dose Management Market (by End User), 2021-2030
Figure 14.69: Rest-of-the-World Radiation Dose Management Market (by Country), 2019-2030
Figure 14.70: Middle East Radiation Dose Management Market, 2019-2030
Figure 14.71: Middle East Radiation Dose Management Market (by End User), 2019-2030
Figure 14.72: Africa Radiation Dose Management Market, 2019-2030
Figure 14.73: Africa Radiation Dose Management Market (by End User), 2019-2030
Figure 15.1: Agfa Gevaert Group - Product Portfolio for Radiation Dose Management Solutions Market
Figure 15.2: Agfa Gevaert Group - Overall Financials, 2017-2019
Figure 15.3: Agfa-Gevaert Group- Revenue (by Segment), 2017-2019
Figure 15.4: Agfa Gevaert Group - Revenue (by Region), 2017-2019
Figure 15.5: Agfa Gevaert Group - R&D Expenditure, 2017-2019
Figure 15.6: SWOT Analysis – Agfa Gevaert Group
Figure 15.7: Bayer AG- Product Portfolio for Radiation Dose Management Market
Figure 15.8: Bayer AG - Overall Financials, 2017-2019
Figure 15.9: Bayer AG - Revenue (by Segment), 2017-2019
Figure 15.10: Bayer AG - Revenue (by Region), 2017-2019
Figure 15.11: Bayer AG- R&D Expenditure, 2017-2019
Figure 15.12: SWOT Analysis – Bayer AG
Figure 15.13: Bracco - Product Portfolio for Radiation Dose Management Market
Figure 15.14: SWOT Analysis - Bracco
Figure 15.15: Canon Inc. - Product Portfolio for Radiation Dose Management Market
Figure 15.16: Canon Inc. - Overall Financials, 2017-2019
Figure 15.17: Canon Inc. - Revenue (by Segment), 2017-2019
Figure 15.18: Canon Inc. - Revenue (by Region), 2017-2019
Figure 15.19: Canon Inc. - R&D Expenditure, 2017-2019
Figure 15.20: SWOT Analysis – Canon Inc.
Figure 15.21: Fujifilm Holdings Corporation - Product Radiation Dose Management Market
Figure 15.22: Fujifilm Holdings Corporation - Overall Financials, 2017-2019
Figure 15.23: Fujifilm Holdings Corporation - Revenue (by Segment), 2017-2019
Figure 15.24: Fujifilm Holdings Corporation - Revenue (by Region), 2017-2019
Figure 15.25: Fujifilm Holdings Corporation - R&D Expenditure, 2017-2019
Figure 15.26: SWOT Analysis - Fujifilm Holdings Corporation
Figure 15.27: Guerbet Group- Product Portfolio for Radiation Dose Management Market
Figure 15.28: Guerbet Group. - Overall Financials, 2017-2019
Figure 15.29: Guerbet Group - Revenue (by Segment), 2017-2019
Figure 15.30: Guerbet Group - Revenue (by Region), 2017-2019
Figure 15.31: SWOT Analysis - Guerbet LLC
Figure 15.32: General Electric Company - Product Portfolio for Radiation Dose Management Market
Figure 15.33: General Electric Company - Overall Financials, 2017-2019
Figure 15.34: General Electric Company - Revenue (by Segment), 2017-2019
Figure 15.35: General Electric Company (GE Healthcare) - Revenue (by Region), 2017-2019
Figure 15.36: General Electric Company - R&D Expenditure, 2017-2019
Figure 15.37: SWOT Analysis - General Electric Company
Figure 15.38: Imalogix - Product Portfolio for Radiation Dose Management Market
Figure 15.39: SWOT Analysis – Imalogix
Figure 15.40: Infinitt Healthcare Co. Ltd- Product Portfolio for Radiation Dose Management Market
Figure 15.41: SWOT Analysis – Infinitt Healthcare Co., Ltd.
Figure 15.42: Koninklijke Philips N.V. - Product Portfolio for Radiation Dose Management Market
Figure 15.43: Koninklijke Philips N.V. - Overall Financials, 2017-2019
Figure 15.44: Koninklijke Philips N.V. - Revenue (by Segment), 2017-2019
Figure 15.45: Koninklijke Philips N.V. - Revenue (by Region), 2017-2019
Figure 15.46: Koninklijke Philips N.V. - R&D Expenditure, 2017-2019
Figure 15.47: SWOT Analysis - Koninklijke Philips N.V.
Figure 15.48: Medic Vision Imaging Solutions Ltd. - Product Portfolio
Figure 15.49: SWOT Analysis – Medic Vision Imaging Solutions Ltd.
Figure 15.50: Medsquare - Product Portfolio for Radiation Dose Management Market
Figure 15.51: SWOT Analysis – Medsquare
Figure 15.52: MyXrayDose, Ltd. - Product Portfolio
Figure 15.53: SWOT Analysis – MyXrayDose, Ltd.
Figure 15.54: Novarad Corporation - Product Portfolio
Figure 15.55: SWOT Analysis – Novarad Corporation
Figure 15.56: PACSHealth, LLC - Product Portfolio for Radiation Dose Management Market
Figure 15.57: SWOT Analysis – PACSHealth, LLC
Figure 15.58: Qaelum NV - Product Portfolio for Radiation Dose Management Market
Figure 15.59: SWOT Analysis – Qaelum NV
Figure 15.60: Sectra AB - Product Portfolio for Radiation Dose Management
Figure 15.61: Sectra AB - Overall Financials, 2017/18-2019/20
Figure 15.62: Sectra AB - Revenue (by Segment), 2017/8-2019/20
Figure 15.63: Sectra AB - Revenue (by Region), 2017/18-2019/20
Figure 15.64: Sectra AB - R&D Expenditure, 2017/18-2019/20
Figure 15.65: SWOT Analysis – Sectra AB
Figure 15.66: SST Group, Inc. - Product Portfolio for Radiation Dose Management Market
Figure 15.67: SWOT Analysis – SST Group Inc.
Figure 15.68: Siemens Healthineers, Inc. - Product Portfolio for Radiation Dose Management Market
Figure 15.69: Siemens Healthineers, Inc. - Overall Financials, 2018-2020
Figure 15.70: Siemens Healthineers, Inc. - Revenue (by Segment), 2018-2020
Figure 15.71: Siemens Healthineers, Inc. - Revenue (by Region), 2018-2020
Figure 15.72: Siemens Healthineers, Inc. - R&D Expenditure, 2018-2020
Figure 15.73: SWOT Analysis - Siemens Healthineers, Inc.
Figure 15.74: Virtual Phantom, Inc.- Product Portfolio for Radiation Dose Management Market
Figure 15.75: SWOT Analysis – Virtual Phantoms Inc.
Figure 1: Global Radiation Dose Management Market Value, 2019-2030
Figure 2: Radiation Dose Management Market, Pre-COVID-19 and Post-COVID-19 Scenario, $Million
Figure 3: Dominating Segments of Global Radiation Dose Management Market, 2020 and 2030
Figure 4: Global Radiation Dose Management Market (by Modality), Share Analysis, 2020-2030
Figure 5: Global Radiation Dose Management Market (by Mode of Deployment), Share Analysis, 2020 and 2030
Figure 6: Global Radiation Dose Management Market (by End Users), Share Analysis, 2020 and 2030
Figure 7: Global Radiation Dose Management Market (by Region), 2020
Figure 8: Key Strategies Incorporated by the Key Players in the Radiation Dose Management Market (January 2012–November 2020)
Figure 9: Market Share Analysis for the Global Radiation Dose Management Market (by Company), 2019
Figure 1.1: Sources of Radiation Exposure in the U.S.
Figure 1.2: Dose From Natural Background Radiation (mSv)
Figure 1.3: Different Types of Radiation Doses
Figure 3.1: Global Radiation Dose Management: Market Segmentation
Figure 4.1: Radiation Dose Management Market Research Methodology
Figure 4.2: Primary Research
Figure 4.3: Secondary Research
Figure 4.4: Considered Factors for Data Prediction and Modeling
Figure 4.5: Total Number of Companies Profiled
Figure 4.6: Assumptions and Limitations
Figure 5.1: Long-, Mid-, and Short-Term Impact of COVID-19 on Radiation Dose Management Market
Figure 5.2: Number of Scans by Imaging Modalities in the U.K. from January 2020– May 2020
Figure 5.3: Radiation Dose Management Market, Pre-COVID-19 and Post-COVID-19 Scenarios, $Million
Figure 5.4: Product Demand for Radiation Dose Management Software
Figure 5.5: Various Technological Opportunity Came During COVID-19
Figure 5.6: Recommendations for Hospitals to Optimize the Radiation Dose Process
Figure 6.1: Historic Evolution of X-Rays
Figure 6.2: Historical Evolution of Radiation Dose Management Software
Figure 6.3: Global Radiation Dose Management Market, 2019-2030
Figure 6.4: Market Dynamics
Figure 6.5: Number of Scans by Imaging Modalities in the U.K. From 2015-16 to 2019-20
Figure 6.6: Geriatric Population (60 Years and Above) Worldwide in Different Regions, 2000, 2015, 2030, and 2050
Figure 6.7: Number of Incidence Cases of Cancer in 2018 and 2040
Figure 6.8: Regulatory Bodies for Radiology Diagnostic Devices
Figure 6.9: Major Concerns Related to Overexposure of Radiation in Medical Imaging Devices and Procedures
Figure 7.1: Share of Key Developments and Strategies, January 2012–November 2020
Figure 7.2: Collaborations, Agreements, and Partnerships (by Company), January 2012–November 2020
Figure 7.3: Product Launches and Approvals (by Company), January 2012– November 2020
Figure 7.4: Regulatory Approvals (by Company), January 2012–November 2020
Figure 7.5: Mergers and Acquisitions (by Company), January 2012–November 2020
Figure 7.6: Market Share Analysis for the Global Radiation Dose Management Market (by Company), 2019
Figure 9.1: Patent Segmentation, by Year
Figure 9.2: Patent Segmentation, by Country
Figure 9.3: Patent Segmentation, by Modality
Figure 9.4: Patent Segmentation, by Modality Type
Figure 10.1: Segmentation of Radiation Dose Management Market, by Modality
Figure 10.2: Global Radiation Dose Management Market (by Modality), Market Share, 2020
Figure 10.3: Global Radiation Dose Management Market (by Modality), 2019-2030
Figure 10.4: Benefits of the CT scan
Figure 10.5: CT Scanner in the Global Radiation Dose Management Market, 2019-2030
Figure 10.6: CT Scanners Radiation Dose Management Market (by Region), 2019-2030
Figure 10.7: X-Ray, CR, and DR in the Global Radiation Dose Management Market, 2019-2030
Figure 10.8: X-Ray, CR, and DR Radiation Dose Management Market (by Region), 2019-2030
Figure 10.9: Mammography Systems in the Global Radiation Dose Management Market, 2019-2030
Figure 10.10: Mammography Systems Radiation Dose Management Market (by Region), 2019-2030
Figure 10.11: Interventional Angiography Systems/Angio CT in the Global Radiation Dose Management Market, 2019-2030
Figure 10.12: Interventional Angiography Systems/Angio CT Radiation Dose Management Market (by Region), 2019-2030
Figure 10.13: Benefits of Fluoroscopy System
Figure 10.14: Fluoroscopy Systems in the Global Radiation Dose Management Market, 2019-2030
Figure 10.15: Fluoroscopy Systems Radiation Dose Management Market (by Region), 2019-2030
Figure 10.16: PET Scanners and SPECT in the Global Radiation Dose Management Market, 2019-2030
Figure 10.17: PET Scanners and SPECT Radiation Dose Management Market (by Region), 2019-2030
Figure 10.18: Hybrid Imaging in the Global Radiation Dose Management Market, 2019-2030
Figure 10.19: Hybrid Imaging Radiation Dose Management Market (by Region), 2019-2030
Figure 11.1: Segmentation of Radiation Dose Management Market, (by Product Type)
Figure 11.2: Global Radiation Dose Management Market (by Product Type), 2020 and 2030
Figure 11.3: Global Radiation Dose Management Market (Radimetrics Enterprise Platform), 2019-2030
Figure 11.4: Installed Base and Number of Customers, 2018 and 2019
Figure 11.5: Compatible Modalities of Radimetrics Enterprise Platform
Figure 11.6: Global Radiation Dose Management Market (DoseWatch), 2019-2030
Figure 11.7: Installed Base and Number of Customers, 2018 and 2019
Figure 11.8: Compatible Modalities of DoseWatch
Figure 11.9: Global Radiation Dose Management Market (teamplay Dose), 2019-2030
Figure 11.10: Installed Base and Number of Customers, 2018 and 2019
Figure 11.11: Compatible Modalities of teamplay Dose
Figure 11.12: Global Radiation Dose Management Market (NEXO [DOSE]), 2019-2030
Figure 11.13: Installed Base and Number of Customers, 2018 and 2019
Figure 11.14: Compatible Modalities of NEXO [DOSE]
Figure 11.15: Global Radiation Dose Management Market ( tqm/Dose and DoseMonitor), 2019-2030
Figure 11.16: Installed Base and Number of Customers, 2019 and 2020
Figure 11.17: Compatible Modalities of tqm/Dose and DoseMonitor
Figure 11.18: Global Radiation Dose Management Market (Radiation Dose Monitor), 2019-2030
Figure 11.19: Installed Base and Number of Customers, 2018 and 2019
Figure 11.20: Compatible Modalities of Radiation Dose Monitor
Figure 11.21: Global Radiation Dose Management Market (Imalogix Platform), 2019-2030
Figure 11.22: Installed Base and Number of Customers, 2018 and 2019
Figure 11.23: Compatible Modalities of Imalogix Platform
Figure 11.24: Global Radiation Dose Management Market (Syncro-Dose), 2019-2030
Figure 11.25: Installed Base and Number of Customers, 2018 and 2019
Figure 11.26: Compatible Modalities of Syncro-Dose
Figure 11.27: Global Radiation Dose Management Market (NovaDose), 2019-2030
Figure 11.28: Installed Base and Number of Customers, 2018 and 2019
Figure 11.29: Compatible Modalities of NovaDose
Figure 11.30: Global Radiation Dose Management Market (DoseWise Portal), 2019-2030
Figure 11.31: Installed Base and Number of Customers, 2018 and 2019
Figure 11.32: Compatible Modalities of DoseWise Portal
Figure 11.33: Global Radiation Dose Management Market (SafeCT), 2019-2030
Figure 11.34: Installed Base and Number of Customers, 2018 and 2019
Figure 11.35: Compatible Modalities of SafeCT
Figure 11.36: Global Radiation Dose Management Market (MyXrayDose), 2019-203
Figure 11.37: Installed Base and Number of Customers, 2018 and 2019
Figure 11.38: Compatible Modalities of MyXrayDose
Figure 11.39: Global Radiation Dose Management Market (DoseM), 2019-2030
Figure 11.40: Installed Base and Number of Customers, 2018 and 2019
Figure 11.41: Compatible Modalities of DoseM
Figure 11.42: Global Radiation Dose Management Market (Dose Tracking System), 2019-2030
Figure 11.43: Installed Base and Number of Customers, 2018 and 2019
Figure 11.44: Compatible Modalities of the Dose Tracking System
Figure 11.45: Global Radiation Dose Management Market (DoseTrack), 2019-2030
Figure 11.46: Installed Base and Number of Customers, 2018 and 2019
Figure 11.47: Compatible Modalities of DoseTrack
Figure 12.1: Segmentation of Radiation Dose Management Market (by Mode of Deployment)
Figure 12.2: Global Radiation Dose Management Market (by Mode of Deployment), 2019-2030
Figure 12.3: Global Radiation Dose Management Installed Base (by Mode of Deployment), 2019-2030
Figure 12.4: Global Radiation Dose Management Market (Web-Based), 2019-2030
Figure 12.5: Web-Based Radiation Dose Management Market (by Region), 2019-2030
Figure 12.6: Global Radiation Dose Management Market (On-Premises), 2019-2030
Figure 12.7: On-Premises Radiation Dose Management Market (by Region), 2019-2030
Figure 12.8: Global Radiation Dose Management Market (Cloud-Based), 2019-2030
Figure 12.9: Cloud-Based Radiation Dose Management Market (by Region), 2019-2030
Figure 13.1: Segmentation of Radiation Dose Management Market (by End User)
Figure 13.2: Global Radiation Dose Management Market (by End User), 2020 and 2030
Figure 13.3: Global Radiation Dose Management Market (Hospital), 2019-2030
Figure 13.4: Global Radiation Dose Management Market (Diagnostic Centers), 2019-2030
Figure 13.5: Global Radiation Dose Management Market (by Others), 2019-2030
Figure 14.1: Global Radiation Dose Management Market (by Region), 2020
Figure 14.2: Global Radiation Dose Management Market (by Region), $Million, 2019-2030
Figure 14.3: North America Radiation Dose Management Market, $Million, 2019-2030
Figure 14.4: North America: Market Dynamics
Figure 14.5: North America: Radiation Dose Management Market (by Modality), 2019-2030
Figure 14.6: North America: Radiation Dose Management Market (by End User), 2019-2030
Figure 14.7: North America: Radiation Dose Management Market (by Country), 2020 and 2030
Figure 14.8: Patient Data of New Cancer Cases by Cancer Type in the U.S.(2020)
Figure 14.9: U.S. Radiation Dose Management Market, 2019-2030
Figure 14.10: U.S. Radiation Dose Management Market (by End User), 2019-2030
Figure 14.11: Number of Units of Imaging Devices in Canada in 2017
Figure 14.12: Key Features of Imaging Devices in Canada
Figure 14.13: Canada Radiation Dose Management Market, 2019-2030
Figure 14.14: Canada Radiation Dose Management Market (by End User), 2019-2030
Figure 14.15: Europe Radiation Dose Management Market, 2019-2030
Figure 14.16: Europe Market Dynamics
Figure 14.17: Europe Radiation Dose Management Market (by Modality), 2019-2030
Figure 14.18: Europe Radiation Dose Management Market (by End User), 2019-2030
Figure 14.19: Europe Radiation Dose Management Market (by Country), 2019-2030
Figure 14.20: Germany Radiation Dose Management Market, 2019-2030
Figure 14.21: Germany Radiation Dose Management Market (by End User), 2019-2030
Figure 14.22: France Radiation Dose Management Market, 2019-2030
Figure 14.23: France Radiation Dose Management Market (by End User), 2019-2030
Figure 14.24: Italy Radiation Dose Management Market, 2019-2030
Figure 14.25: Italy Radiation Dose Management Market (by End User), 2019-2030
Figure 14.26: U.K. Radiation Dose Management Market, 2019-2030
Figure 14.27: U.K. Radiation Dose Management Market (by End User), 2019-2030
Figure 14.28: Spain Radiation Dose Management Market, 2019-2030
Figure 14.29: Spain Radiation Dose Management Market (by End User), 2019-2030
Figure 14.30: Netherlands Radiation Dose Management Market, 2019-2030
Figure 14.31: Netherlands Radiation Dose Management Market (by End User), 2019-2030
Figure 14.32: Russia Radiation Dose Management Market, 2019-2030
Figure 14.33: Russia Radiation Dose Management Market (by End User), 2019-2030
Figure 14.34: Rest-of-Europe Radiation Dose Management Market, 2019-2030
Figure 14.35: Rest-of-Europe Radiation Dose Management Market (by End User), 2019-2030
Figure 14.36: Asia-Pacific Radiation Dose Management Market, $Million, 2019-2030
Figure 14.37: Asia-Pacific Market Dynamics
Figure 14.38: Asia-Pacific Radiation Dose Management Market (by Modality), 2019-2030
Figure 14.39: Asia-Pacific Radiation Dose Management Market (by End User), 2019-2030
Figure 14.40: Asia-Pacific Radiation Dose Management Market (by Country), 2019-2030
Figure 14.41: Recommendations by the Science Council of Japan (2017)
Figure 14.42: Japan Radiation Dose Management Market, 2019-2030
Figure 14.43: Japan Radiation Dose Management Market (by End User), 2019-2030
Figure 14.44: China Radiation Dose Management Market, 2019-2030
Figure 14.45: China Radiation Dose Management Market (by End User), 2019-2030
Figure 14.46: Australia and New Zealand Radiation Dose Management Market, 2019-2030
Figure 14.47: Australia and New Zealand Radiation Dose Management Market (by End User), 2019-2030
Figure 14.48: South Korea Radiation Dose Management Market, 2019-2030
Figure 14.49: South Korea Radiation Dose Management Market (by End User), 2019-2030
Figure 14.50: India Radiation Dose Management Market, 2019-2030
Figure 14.51: India Radiation Dose Management Market (by End User), 2019-2030
Figure 14.52: Rest-of-Asia-Pacific Radiation Dose Management Market, 2019-2030
Figure 14.53: Rest of Asia-Pacific Radiation Dose Management Market (by End User), 2019-2030
Figure 14.54: Latin America Radiation Dose Management Market, 2019-2030
Figure 14.55: Latin America Market Dynamics
Figure 14.56: Latin America Radiation Dose Management Market (by Modality), 2019-2030
Figure 14.57: Latin America Radiation Dose Management Market (by End User), 2019-2030
Figure 14.58: Latin America Radiation Dose Management Market (by Country), 2019-2030
Figure 14.59: Brazil Radiation Dose Management Market, 2021-2030
Figure 14.60: Brazil Radiation Dose Management Market (by End User), 2019-2030
Figure 14.61: Mexico Radiation Dose Management Market, 2019-2030
Figure 14.62: Mexico Radiation Dose Management Market (by End User), 2019-2030
Figure 14.63: Rest-of-Latin America Radiation Dose Management Market, 2019-2030
Figure 14.64: Rest-of-Latin America Radiation Dose Management Market (by End User), 2019-2030
Figure 14.65: Rest-of-the-World Radiation Dose Management Market, 2019-2030
Figure 14.66: Middle East and Africa Market Dynamics
Figure 14.67: Rest-of-the-World Radiation Dose Management Market (by Modality), 2019-2030
Figure 14.68: Rest-of-the-World Radiation Dose Management Market (by End User), 2021-2030
Figure 14.69: Rest-of-the-World Radiation Dose Management Market (by Country), 2019-2030
Figure 14.70: Middle East Radiation Dose Management Market, 2019-2030
Figure 14.71: Middle East Radiation Dose Management Market (by End User), 2019-2030
Figure 14.72: Africa Radiation Dose Management Market, 2019-2030
Figure 14.73: Africa Radiation Dose Management Market (by End User), 2019-2030
Figure 15.1: Agfa Gevaert Group - Product Portfolio for Radiation Dose Management Solutions Market
Figure 15.2: Agfa Gevaert Group - Overall Financials, 2017-2019
Figure 15.3: Agfa-Gevaert Group- Revenue (by Segment), 2017-2019
Figure 15.4: Agfa Gevaert Group - Revenue (by Region), 2017-2019
Figure 15.5: Agfa Gevaert Group - R&D Expenditure, 2017-2019
Figure 15.6: SWOT Analysis – Agfa Gevaert Group
Figure 15.7: Bayer AG- Product Portfolio for Radiation Dose Management Market
Figure 15.8: Bayer AG - Overall Financials, 2017-2019
Figure 15.9: Bayer AG - Revenue (by Segment), 2017-2019
Figure 15.10: Bayer AG - Revenue (by Region), 2017-2019
Figure 15.11: Bayer AG- R&D Expenditure, 2017-2019
Figure 15.12: SWOT Analysis – Bayer AG
Figure 15.13: Bracco - Product Portfolio for Radiation Dose Management Market
Figure 15.14: SWOT Analysis - Bracco
Figure 15.15: Canon Inc. - Product Portfolio for Radiation Dose Management Market
Figure 15.16: Canon Inc. - Overall Financials, 2017-2019
Figure 15.17: Canon Inc. - Revenue (by Segment), 2017-2019
Figure 15.18: Canon Inc. - Revenue (by Region), 2017-2019
Figure 15.19: Canon Inc. - R&D Expenditure, 2017-2019
Figure 15.20: SWOT Analysis – Canon Inc.
Figure 15.21: Fujifilm Holdings Corporation - Product Radiation Dose Management Market
Figure 15.22: Fujifilm Holdings Corporation - Overall Financials, 2017-2019
Figure 15.23: Fujifilm Holdings Corporation - Revenue (by Segment), 2017-2019
Figure 15.24: Fujifilm Holdings Corporation - Revenue (by Region), 2017-2019
Figure 15.25: Fujifilm Holdings Corporation - R&D Expenditure, 2017-2019
Figure 15.26: SWOT Analysis - Fujifilm Holdings Corporation
Figure 15.27: Guerbet Group- Product Portfolio for Radiation Dose Management Market
Figure 15.28: Guerbet Group. - Overall Financials, 2017-2019
Figure 15.29: Guerbet Group - Revenue (by Segment), 2017-2019
Figure 15.30: Guerbet Group - Revenue (by Region), 2017-2019
Figure 15.31: SWOT Analysis - Guerbet LLC
Figure 15.32: General Electric Company - Product Portfolio for Radiation Dose Management Market
Figure 15.33: General Electric Company - Overall Financials, 2017-2019
Figure 15.34: General Electric Company - Revenue (by Segment), 2017-2019
Figure 15.35: General Electric Company (GE Healthcare) - Revenue (by Region), 2017-2019
Figure 15.36: General Electric Company - R&D Expenditure, 2017-2019
Figure 15.37: SWOT Analysis - General Electric Company
Figure 15.38: Imalogix - Product Portfolio for Radiation Dose Management Market
Figure 15.39: SWOT Analysis – Imalogix
Figure 15.40: Infinitt Healthcare Co. Ltd- Product Portfolio for Radiation Dose Management Market
Figure 15.41: SWOT Analysis – Infinitt Healthcare Co., Ltd.
Figure 15.42: Koninklijke Philips N.V. - Product Portfolio for Radiation Dose Management Market
Figure 15.43: Koninklijke Philips N.V. - Overall Financials, 2017-2019
Figure 15.44: Koninklijke Philips N.V. - Revenue (by Segment), 2017-2019
Figure 15.45: Koninklijke Philips N.V. - Revenue (by Region), 2017-2019
Figure 15.46: Koninklijke Philips N.V. - R&D Expenditure, 2017-2019
Figure 15.47: SWOT Analysis - Koninklijke Philips N.V.
Figure 15.48: Medic Vision Imaging Solutions Ltd. - Product Portfolio
Figure 15.49: SWOT Analysis – Medic Vision Imaging Solutions Ltd.
Figure 15.50: Medsquare - Product Portfolio for Radiation Dose Management Market
Figure 15.51: SWOT Analysis – Medsquare
Figure 15.52: MyXrayDose, Ltd. - Product Portfolio
Figure 15.53: SWOT Analysis – MyXrayDose, Ltd.
Figure 15.54: Novarad Corporation - Product Portfolio
Figure 15.55: SWOT Analysis – Novarad Corporation
Figure 15.56: PACSHealth, LLC - Product Portfolio for Radiation Dose Management Market
Figure 15.57: SWOT Analysis – PACSHealth, LLC
Figure 15.58: Qaelum NV - Product Portfolio for Radiation Dose Management Market
Figure 15.59: SWOT Analysis – Qaelum NV
Figure 15.60: Sectra AB - Product Portfolio for Radiation Dose Management
Figure 15.61: Sectra AB - Overall Financials, 2017/18-2019/20
Figure 15.62: Sectra AB - Revenue (by Segment), 2017/8-2019/20
Figure 15.63: Sectra AB - Revenue (by Region), 2017/18-2019/20
Figure 15.64: Sectra AB - R&D Expenditure, 2017/18-2019/20
Figure 15.65: SWOT Analysis – Sectra AB
Figure 15.66: SST Group, Inc. - Product Portfolio for Radiation Dose Management Market
Figure 15.67: SWOT Analysis – SST Group Inc.
Figure 15.68: Siemens Healthineers, Inc. - Product Portfolio for Radiation Dose Management Market
Figure 15.69: Siemens Healthineers, Inc. - Overall Financials, 2018-2020
Figure 15.70: Siemens Healthineers, Inc. - Revenue (by Segment), 2018-2020
Figure 15.71: Siemens Healthineers, Inc. - Revenue (by Region), 2018-2020
Figure 15.72: Siemens Healthineers, Inc. - R&D Expenditure, 2018-2020
Figure 15.73: SWOT Analysis - Siemens Healthineers, Inc.
Figure 15.74: Virtual Phantom, Inc.- Product Portfolio for Radiation Dose Management Market
Figure 15.75: SWOT Analysis – Virtual Phantoms Inc.
